Wells Pharmacy Recalls MIC/B-Complex Injectable Due to Sterility Concerns
Wells Pharmacy Network LLC is recalling 984 vials of MIC/B-Complex Injectable because the product lacks assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for drug recalls involving potential health risks.
Plain-English summary
Wells Pharmacy Network LLC is recalling 984 vials of MIC/B-Complex 15 mg/50 mg/100 mg/mL Injectable, 30 mL vial. The product was compounded by Wells Pharmacy in Ocala, Florida, and distributed nationwide.
The recall was initiated due to a lack of assurance of sterility. The affected product includes all lot codes prepared between February 22, 2016, and September 14, 2016, that are within their expiry date. Specific known lot codes include 04052016@5, 04082016@3, 04182016@37, 05032016@2, 05182016@3, 05232016@22, 06072016@18, 06282016@45, 07252016@52, and 08262016@8.
Consumers and healthcare providers should check their inventory for these specific lot codes and dates. If the product is found, it should be returned to the pharmacy or the recalling firm for disposal or credit.
The recalled product
- Product
- MIC/B-COMPLEX 15 mg/50 mg/100 mg/mL Injectable, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Manufacturer
- Wells Pharmacy Network LLC
- Category
- Drug — Injectable
- Hazard
- Affected units
- 984
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- All lot codes of product prepared between 02/22/2016 and 09/14/2016
- within expiry. Known lot code: 04052016@5
- 04082016@3
- 04182016@37
- 05032016@2
- 05182016@3
- 05232016@22
- 06072016@18
- 06282016@45
- 07252016@52
- 08262016@8.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 97 recalled by Wells Pharmacy Network LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 97 products in this recall →Related recalls
Same manufacturer · Wells Pharmacy Network LLC
See all →- SevereWells Pharmacy Recalls Injectable Compounds Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereWells Pharmacy Recalls Compounded Chorionic Gonadotropin Injectable Kits
FDA (Drugs) · 2017-01-11
- SevereWells Pharmacy Recalls Compounded Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereWells Pharmacy Recalls Trimix with Atropine Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereWells Pharmacy Recalls Testosterone Cypionate Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereB-Complex Injectable Recalled Due to Sterility Concerns
FDA (Drugs) · 2013-06-12
- SevereBella Pharmaceuticals Recalls B-Complex Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereCompounding Pharmacy Recalls MIC-B Complex Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereGreen Valley Drugs Recalls B-Complex Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereUS Compounding Recalls MIC Combo Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereKey Pharmacy Recalls Methyl-B12 Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24